PlusCBD™ Oil Roll-On publish at 945 Kroger Stores in 17 U.S. States
LAS VEGAS, NEVADA, June 12, 2019 (WORLD NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a supplier that is preeminent maker of hemp CBD products, is very happy to announce further expansion of its industry-dominating PlusCBD™ Oil brand name because of the Kroger Co. (NYSE:KR).
The Company’s expanded distribution that is retail the launch of CV Sciences’ new PlusCBD Oil™ Roll-Ons in 945 Kroger stores across a lot of its retail ads, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC and Smiths places in 17 U.S. states. PlusCBD™ Oil Roll-On, for sale in 200mg CBD and additional Strength 500mg formulations, is infused with concentrated CBD from agricultural hemp plant parts, warming camphor and menthol that is cooling. Fashioned with its Gold Formula focused complete spectrum hemp extract, the Roll-Ons offer high intensity help in a easy-to-use application. The Company’s best-selling PlusCBD™ Oil Extra Strength and Original Balms may also be available at the participating Kroger areas. All PlusCBD™ Oil topical products contain no phthalates, sulfates or parabens and are made without artificial dyes or scents to meet consumer expectations of clean ingredients.
As talked about from the Company’s very first quarter 2019 profits turn to May 8, 2019, CV Sciences’ recent circulation gains consist of accessibility to PlusCBD™ Oil Extra Strength Balm in a preliminary launch at CVS Pharmacy stores. By adding 945 Kroger places and brand new circulation into other leading Food, Drug and Mass (FDM) stores, at the time of June 12, 2019, PlusCBD™ Oil branded items are obtainable in 4,591 shops, up from 3,308 shops at the time of March 31, 2019, a rise of 38.7% throughout the previous 8 weeks.
“We are pleased to partner with Kroger and introduce our brand new Roll-On topical as we visit the website carry on our quick expansion to the FDM channel,” said Joseph Dowling, ceo. “Kroger, CVS Pharmacy, and other leading nationwide retailers are keenly conscious of the increased customer need for hemp-based CBD products and they’re partnering with CV Sciences as a result of our commitment that is unwavering to and quality. Our company is at the start of what we think will soon be acceptance that is broad of products across national FDM accounts and then we anticipate our continued development once we expand shop count and SKUs with your retail lovers.”
PlusCBD™ Oil Extra Strength Balm ranks no. 1 in product product sales both in the U.S. that is total Natural and complete U.S. MULO (Multi Outlet) throughout the last 52 months* among CBD services and services and products within Topical Analgesics, relating to SPINS and IRI information, correspondingly. Brightfield Group, a prominent predictive analytics and researching the market company when it comes to CBD market, expects $1.3 billion in product product sales of CBD topicals in 2019, having an element annual development price of 169% from 2018 – 2022.
About CV Sciences, Inc.
CV Sciences, Inc. (OTCQB:CVSI) runs two distinct company sections: a customer item unit centered on production, advertising and attempting to sell plant-based CBD items to a variety of market sectors; and a medication development unit focused on developing and commercializing CBD-based novel therapeutics using CBD. The Company’s PlusCBD™ Oil could be the brand that is top-selling of CBD available on the market, according to SPINS, the best provider of syndicated data and insights when it comes to normal, natural and specialty items industry. CV Sciences, Inc. has main offices and facilities in hillcrest, California and Las Vegas, Nevada. Extra information can be obtained from OTCMarkets.com or by visiting www.cvsciences.com.
This pr release may include particular statements that are forward-looking information, as defined in the meaning of Section 27A of this Securities Act of 1933 and Section 21E of this Securities Exchange Act of 1934, and it is susceptible to the secure Harbor produced by those parts. This material contains statements about anticipated future occasions and/or economic results which are forward-looking in general and susceptible to risks and uncertainties. Such statements that are forward-looking meaning involve risks, uncertainties.